OXALIPLATIN — all Canadian products
22 DINs
10 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is OXALIPLATIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02444763 | OXALIPLATIN | PFIZER CANADA ULC | Solution | Intravenous | OXALIPLATIN 5 MG | Marketed | |
| 02436957 | OXALIPLATIN INJECTION | SANDOZ CANADA INCORPORATED | Solution | Intravenous | OXALIPLATIN 5 MG | Marketed | |
| 02435071 | OXALIPLATIN INJECTION | TEVA CANADA LIMITED | Solution | Intravenous | OXALIPLATIN 5 MG | Marketed | |
| 02536757 | OXALIPLATIN INJECTION | EUGIA PHARMA INC. | Solution | Intravenous | OXALIPLATIN 5 MG | Approved | |
| 02454084 | OXALIPLATIN INJECTION | GENERIC MEDICAL PARTNERS INC | Solution | Intravenous | OXALIPLATIN 5 MG | Approved | |
| 02532131 | OXALIPLATIN INJECTION | AURO PHARMA INC | Solution | Intravenous | OXALIPLATIN 5 MG | Approved | |
| 02436167 | OXALIPLATIN INJECTION | ACCORD HEALTHCARE INC | Solution | Intravenous | OXALIPLATIN 5 MG | Approved | |
| 02433206 | OXALIPLATIN INJECTION USP | STRIDES PHARMA CANADA INC | Solution | Intravenous | OXALIPLATIN 5 MG | Approved | |
| 02457423 | OXALIPLATIN INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | Intravenous | OXALIPLATIN 5 MG | Marketed | |
| 02458403 | OXALIPLATIN INJECTION, USP | DR REDDY'S LABORATORIES LTD | Solution | Intravenous | OXALIPLATIN 5 MG | Marketed | |
| 02430533 | ACT OXALIPLATIN | ACTAVIS PHARMA COMPANY | Powder For Solution | Intravenous | OXALIPLATIN 100 MG | Cancelled Pre Market | |
| 02432617 | ACT OXALIPLATIN | ACTAVIS PHARMA COMPANY | Solution | Intravenous | OXALIPLATIN 5 MG | Cancelled Post Market | |
| 02430525 | ACT OXALIPLATIN | ACTAVIS PHARMA COMPANY | Powder For Solution | Intravenous | OXALIPLATIN 50 MG | Cancelled Pre Market | |
| 02296284 | ELOXATIN | SANOFI-AVENTIS CANADA INC | Solution | Intravenous | OXALIPLATIN 5 MG | Cancelled Post Market | |
| 02296276 | ELOXATIN | SANOFI-AVENTIS CANADA INC | Powder For Solution | Intravenous | OXALIPLATIN 100 MG | Cancelled Post Market | |
| 02296268 | ELOXATIN | SANOFI-AVENTIS CANADA INC | Powder For Solution | Intravenous | OXALIPLATIN 50 MG | Cancelled Post Market | |
| 02413841 | OXALIPLATIN FOR INJECTION | HOSPIRA HEALTHCARE ULC | Powder For Solution | Intravenous | OXALIPLATIN 100 MG | Cancelled Pre Market | |
| 02413833 | OXALIPLATIN FOR INJECTION | HOSPIRA HEALTHCARE ULC | Powder For Solution | Intravenous | OXALIPLATIN 50 MG | Cancelled Pre Market | |
| 02431688 | OXALIPLATIN INJECTION | HOSPIRA HEALTHCARE ULC | Solution | Intravenous | OXALIPLATIN 5 MG | Cancelled Pre Market | |
| 02437074 | PMS-OXALIPLATIN | PHARMASCIENCE INC | Solution | Intravenous | OXALIPLATIN 5 MG | Cancelled Post Market | |
| 02449692 | TARO-OXALIPLATIN | TARO PHARMACEUTICALS INC | Solution | Intravenous | OXALIPLATIN 5 MG | Cancelled Post Market | |
| 02446227 | TEVA-OXALIPLATIN INJECTION | TEVA CANADA LIMITED | Solution | Intravenous | OXALIPLATIN 5 MG | Cancelled Pre Market |
Browse other molecules: